Differences in outcome between the NICE-SUGAR and Leuven trials: biological mechanisms of intensive glucose control in critically ill patients

Crit Care Resusc. 2009 Sep;11(3):178-9.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Blood Glucose / analysis*
  • Critical Illness*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Insulin / therapeutic use*
  • Intensive Care Units
  • Multicenter Studies as Topic
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin